Search
Cocaine-Related Disorders Clinical Trials
A listing of 2 Cocaine-Related Disorders clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 2 of 2
There are currently 2 active clinical trials seeking participants for Cocaine-Related Disorders research studies. The states with the highest number of trials for Autism participants are California, New York, Texas and Maryland.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Hyperacusis Activities Treatment-Online Study
Recruiting
Are you experiencing hyperacusis? If so, we are recruiting adults with hyperacusis to complete a clinical trial supported by the National Institutes of Health. The study involves participating in a remote counseling program and sound therapy trial for hyperacusis, Hyperacusis Activities Treatment-Online.
Conditions:
Hyperacusis
Tinnitus
Hearing Loss
Neurocircuit Strategy to Decrease Cocaine Cue Reactivity
Recruiting
The overarching goal of this project is to examine the effect of combining theta burst stimulation (TBS) and N-acetylcysteine (NAC) on cocaine craving and brain response to cocaine-related images.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/28/2023
Locations: Medical University of South Carolina, Charleston, South Carolina
Conditions: Cocaine-Related Disorders
Targeting Anhedonia in Cocaine Use Disorder
Recruiting
The purpose of this study is to examine anhedonia as a potential moderator of treatment outcomes for Cocaine Use Disorder (CUD). Specifically, this study will investigate how anhedonia affects outcomes in contingency management (CM) treatment for CUD and whether anhedonia mediates the effects of adjunctive treatment with a dopaminergic (DAergic) drug, d-amphetamine, on outcomes in CM for CUD, as well as investigate the contribution of anhedonia to overall CUD severity.
Gender:
All
Ages:
Between 18 years and 60 years
Trial Updated:
04/20/2022
Locations: University of Illinois at Chicago, Chicago, Illinois
Conditions: Cocaine-Related Disorders, Anhedonia
1 - 2 of 2